Risk factors for de novo hepatitis B during solid cancer treatment.
Sugimoto R, Furukawa M, Senju T, Aratake Y, Shimokawa M, Tanaka Y, Inada H, Noguchi T, Lee L, Miki M, Maruyama Y, Hashimoto R, Hisano T.
Sugimoto R, et al. Among authors: hisano t.
World J Clin Cases. 2020 Dec 26;8(24):6264-6273. doi: 10.12998/wjcc.v8.i24.6264.
World J Clin Cases. 2020.
PMID: 33392307
Free PMC article.